AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6861819 — intervention group
Group type: COMPARATOR
Intervention: Cystectomy alone (no preoperative irradiation)
Number of subjects: 44
Study 31818048 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal vibration stimulation
Number of subjects: 300
Study 31818048 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking exercise
Number of subjects: 300
Study 31818048 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified in detail)
Number of subjects: 300
Study 31409366 — intervention group
Group type: EXPERIMENTAL
Intervention: WNJ SJOV Group
Number of subjects: 100
Study 31409366 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 100
Study 28253863 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 μg/kg/h after a loading dose of 1.0 μg/kg for 10 min)
Number of subjects: 87
Study 28253863 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (1.6 μg/ml target effect site concentration)
Number of subjects: 87
Study 28253863 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of propofol and dexmedetomidine (M group)
Number of subjects: 87
Study 28253863 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D group)
Number of subjects: 87
Study 28253863 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (P group)
Number of subjects: 87
Study 26844873 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide LAR (40 mg, n = 14)
Number of subjects: 27
Study 26844873 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 27
Study 24954822 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 217
Study 24954822 — intervention group
Group type: COMPARATOR
Intervention: Supportive Nondirective Therapy (SNDT)
Number of subjects: 217
Study 22089179 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga exercise group (n = 8)
Number of subjects: 16
Study 22089179 — intervention group
Group type: COMPARATOR
Intervention: No exercise control group (n = 8)
Number of subjects: 16
Study 18976370 — intervention group
Group type: EXPERIMENTAL
Intervention: ErythroSave
Number of subjects: 20
Study 18976370 — intervention group
Group type: COMPARATOR
Intervention: Control (ordinary syringes)
Number of subjects: 20
Study 17598783 — intervention group
Group type: EXPERIMENTAL
Intervention: RELATE with therapist assistance
Number of subjects: 39
Study 17598783 — intervention group
Group type: EXPERIMENTAL
Intervention: RELATE without therapist assistance
Number of subjects: 39
Study 17598783 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 15726912 — intervention group
Group type: COMPARATOR
Intervention: Menotropins only (group A)
Number of subjects: 219
Study 15726912 — intervention group
Group type: EXPERIMENTAL
Intervention: Menotropins plus mini-dose GnRH-analog (600 microg/day) (group B)
Number of subjects: 219
Study 15726912 — intervention group
Group type: EXPERIMENTAL
Intervention: Menotropins plus standard dose GnRH-analog (900 microg/day) (group C)
Number of subjects: 219
Study 15726912 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH-analog included in the protocol (groups B and C)
Number of subjects: 219
Study 15726912 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 219
Study 12043876 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐5 microsurgical ultrasonic instrument (stainless steel)
Number of subjects: 40
Study 12043876 — intervention group
Group type: EXPERIMENTAL
Intervention: KiS microsurgical ultrasonic instrument (zirconium nitride-coated)
Number of subjects: 40
Study 9807605 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 48-6791
Number of subjects: 76
Study 9807605 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 76
Study 7631946 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% glucose in lactated Ringer's solution (D2LR)
Number of subjects: 60
Study 7631946 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose in lactated Ringer's solution (D5LR)
Number of subjects: 60
Study 7631946 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's solution (LR) alone
Number of subjects: 60
Study 7631946 — intervention group
Group type: COMPARATOR
Intervention: Glucose-free infusion (LR group)
Number of subjects: 60
Study 7631946 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% glucose in lactated Ringer's solution (D2LR) and 5% glucose in lactated Ringer's solution (D5LR)
Number of subjects: 60
Study 7631946 — intervention group
Group type: COMPARATOR
Intervention: Glucose-free solution (LR group)
Number of subjects: 60
Study 7631946 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 2189428 — intervention group
Group type: EXPERIMENTAL
Intervention: No gown (experimental group)
Number of subjects: 452
Study 2189428 — intervention group
Group type: COMPARATOR
Intervention: Gown (control group)
Number of subjects: 452
Study 421509 — intervention group
Group type: EXPERIMENTAL
Intervention: dry-skin (triethanolamine) soap
Number of subjects: 50
Study 421509 — intervention group
Group type: COMPARATOR
Intervention: hard-milled soap
Number of subjects: 50
Study 31164366 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic Tool to Reduce Inappropriate Prescribing (STRIP) intervention
Number of subjects: 4
Study 31164366 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 4
Study 31164366 — intervention group
Group type: EXPERIMENTAL
Intervention: STRIP intervention
Number of subjects: 4
Study 28590244 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab 300 mg administered as two 1‐mL subcutaneous injections every 2 weeks
Number of subjects: 60
Study 28590244 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab 300 mg administered as one 2‐mL injection delivered over different rates (10 seconds, 1 minute, 12 minutes)
Number of subjects: 60
Study 28590244 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab 300 mg administered by different injection rates
Number of subjects: 60
Study 26446596 — intervention group
Group type: EXPERIMENTAL
Intervention: BP-BES
Number of subjects: 3235
Study 26446596 — intervention group
Group type: COMPARATOR
Intervention: DP-EES
Number of subjects: 3235
Study 22362618 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually delivered personalized alcohol feedback
Number of subjects: 173
Study 22362618 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronically delivered personalized alcohol feedback
Number of subjects: 173
Study 22362618 — intervention group
Group type: COMPARATOR
Intervention: Group-delivered personalized alcohol feedback
Number of subjects: 173
Study 21336615 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaolin-impregnated pads
Number of subjects: 118
Study 21336615 — intervention group
Group type: COMPARATOR
Intervention: Manual compression without kaolin-impregnated pads
Number of subjects: 118
Study 19432292 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug acquisition
Number of subjects: 99
Study 19432292 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical services
Number of subjects: 99
Study 19432292 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical devices
Number of subjects: 99
Study 19432292 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of productivity and absentism
Number of subjects: 99
Study 19432292 — intervention group
Group type: EXPERIMENTAL
Intervention: Total costs
Number of subjects: 99
Study 19432292 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickness absence days
Number of subjects: 99
Study 19432292 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital treatment days
Number of subjects: 99
Study 19432292 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antidiabetic drug sales
Number of subjects: 99
Study 19432292 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulins and analogs sales
Number of subjects: 99
Study 16899650 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime Pass Program (BPP)
Number of subjects: 19
Study 16899650 — intervention group
Group type: COMPARATOR
Intervention: Monitoring Control
Number of subjects: 19
Study 14962353 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined monoamine depletion (CMD) condition
Number of subjects: 10
Study 14962353 — intervention group
Group type: COMPARATOR
Intervention: Balanced control (B) condition
Number of subjects: 10
Study 11491193 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 9387943 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihistamines
Number of subjects: 1139
Study 9387943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1139
Study 8191660 — intervention group
Group type: EXPERIMENTAL
Intervention: He‐Ne laser treatment (wavelength 0.63 microns, light spot diameter 5 mm, energy 2 mWt, session duration 240 sec, 10 sessions)
Number of subjects: 23
Study 8191660 — intervention group
Group type: COMPARATOR
Intervention: Control group (17 eyes of the same patients)
Number of subjects: 23
Study 3321890 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration solution with powdered rice and Dal moong
Number of subjects: 60
Study 3321890 — intervention group
Group type: COMPARATOR
Intervention: Standard WHO oral rehydration salt solution (ORS)
Number of subjects: 60
Study 30023053 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated post‐partum family planning and maternal and newborn health (PPFP‐MNH) interventions
Number of subjects: 8
Study 30023053 — intervention group
Group type: COMPARATOR
Intervention: Maternal and newborn health (MNH) interventions only
Number of subjects: 8
Study 27012873 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g oral glucose
Number of subjects: 32
Study 27012873 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g oral glucose
Number of subjects: 32
Study 27012873 — intervention group
Group type: EXPERIMENTAL
Intervention: PostOP
Number of subjects: 32
Study 27012873 — intervention group
Group type: COMPARATOR
Intervention: LC and OC
Number of subjects: 32
Study 25912695 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (10 mg twice daily for 7 days, followed by 5 mg twice daily for 23 weeks)
Number of subjects: 80
Study 25912695 — intervention group
Group type: COMPARATOR
Intervention: UFH/warfarin (control treatment)
Number of subjects: 80
Study 25912695 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 80
Study 25912695 — intervention group
Group type: COMPARATOR
Intervention: UFH/warfarin
Number of subjects: 80
Study 25912695 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban and UFH/warfarin
Number of subjects: 80
Study 21598237 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic radiotherapy to postchemotherapy tumor extent
Number of subjects: 85
Study 21598237 — intervention group
Group type: COMPARATOR
Intervention: Thoracic radiotherapy to prechemotherapy tumor extent (Control)
Number of subjects: 85
Study 21598237 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms omitted elective nodal irradiation
Number of subjects: 85
Study 21598237 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rates
Number of subjects: 85
Study 20651000 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of mental disorders plus feedback to individuals and caregivers
Number of subjects: 836
Study 20651000 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 836
Study 17998493 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole, 1 double-strength tablet twice daily for 3 days
Number of subjects: 338
Study 17998493 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrofurantoin, 100 mg twice daily for 5 days
Number of subjects: 338
Study 17998493 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (nonsusceptible isolate)
Number of subjects: 338
Study 15738432 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal test of capacity followed by request for consent or assent from a proxy
Number of subjects: 0
Study 15738432 — intervention group
Group type: COMPARATOR
Intervention: Combined informal capacity/consent process
Number of subjects: 0
Study 12202434 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-step thawing method
Number of subjects: 293
Study 12202434 — intervention group
Group type: COMPARATOR
Intervention: 2-step thawing method
Number of subjects: 293
Study 12202434 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall clinical pregnancies from thawed blastocysts
Number of subjects: 293
Study 12202434 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall live births from thawed blastocysts
Number of subjects: 293
Study 9659676 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised training
Number of subjects: 100
Study 9659676 — intervention group
Group type: COMPARATOR
Intervention: Self-monitored training
Number of subjects: 100
Study 7510911 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg
Number of subjects: 0
Study 2508287 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous nitroglycerin patches
Number of subjects: 26
Study 2508287 — intervention group
Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 26
Study 1102557 — intervention group
Group type: EXPERIMENTAL
Intervention: Velvet pad rinse technique
Number of subjects: 0
Study 1102557 — intervention group
Group type: COMPARATOR
Intervention: Velvet pad imprint method
Number of subjects: 0
Study 31042420 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 581
Study 31042420 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 581
Study 31042420 — intervention group
Group type: COMPARATOR
Intervention: CMS classification
Number of subjects: 581
Study 29716843 — intervention group
Group type: EXPERIMENTAL
Intervention: Active taVNS (tragus stimulation) with parameters 500μs 10 Hz
Number of subjects: 35
Study 29716843 — intervention group
Group type: EXPERIMENTAL
Intervention: Active taVNS (tragus stimulation) with parameters 500μs 25 Hz
Number of subjects: 35
Study 29716843 — intervention group
Group type: EXPERIMENTAL
Intervention: Active taVNS (tragus stimulation)
Number of subjects: 35
Study 29716843 — intervention group
Group type: COMPARATOR
Intervention: Control (earlobe stimulation)
Number of subjects: 35
Study 27049323 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 60 mg
Number of subjects: 120
Study 27049323 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine 30 mg
Number of subjects: 120
Study 27049323 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 120
Study 27049323 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 120
Study 25277335 — intervention group
Group type: EXPERIMENTAL
Intervention: MGuard embolic protection stent
Number of subjects: 431
Study 25277335 — intervention group
Group type: COMPARATOR
Intervention: Standard metallic stents
Number of subjects: 431
Study 21429719 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 long chain polyunsaturated fatty acids (3.7 g/d providing 1.7 g/d EPA and 1.2 g/d DHA)
Number of subjects: 20
Study 21429719 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg/d)
Number of subjects: 20
Study 21429719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21151623 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol SR 200 mg tablet (test product)
Number of subjects: 0
Study 21151623 — intervention group
Group type: COMPARATOR
Intervention: Reference product (tramadol SR 200 mg tablet)
Number of subjects: 0
Study 18154655 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate + sulphadoxine-pyrimethamine
Number of subjects: 218
Study 18154655 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 218
Study 18154655 — intervention group
Group type: COMPARATOR
Intervention: Sulphadoxine-pyrimethamine alone
Number of subjects: 218
Study 15756485 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including educational and organizational components, technical devices to reduce fall-related injuries
Number of subjects: 200
Study 15756485 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 200
Study 15756485 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention
Number of subjects: 200
Study 12411225 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (once daily for 6 weeks)
Number of subjects: 171
Study 12411225 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once daily for 6 weeks)
Number of subjects: 171
Study 9708652 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrestenotic PTCA
Number of subjects: 890
Study 7898297 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrally-framed information about chemotherapeutic treatment
Number of subjects: 90
Study 7898297 — intervention group
Group type: EXPERIMENTAL
Intervention: Positively-framed information about chemotherapeutic treatment
Number of subjects: 90
Study 7898297 — intervention group
Group type: EXPERIMENTAL
Intervention: Negatively-framed information about chemotherapeutic treatment
Number of subjects: 90
Study 7898297 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 90
Study 7898297 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 90
Study 7898297 — intervention group
Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 90
Study 7898297 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial entry preferences
Number of subjects: 90
Study 2651329 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 6
Study 212171 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain irradiation (2000 rad in 2 weeks)
Number of subjects: 341
Study 212171 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course local irradiation (4200 rad in 3 weeks)
Number of subjects: 341
Study 212171 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic brain irradiation (low doses)
Number of subjects: 341
Study 212171 — intervention group
Group type: COMPARATOR
Intervention: Intermediate course irradiation (5000 rad in 5 weeks)
Number of subjects: 341
Study 28810442 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐administered cognitive behavioral treatment
Number of subjects: 54
Study 28810442 — intervention group
Group type: COMPARATOR
Intervention: Health education (control)
Number of subjects: 54
Study 28665989 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS + exercise (AT+EX)
Number of subjects: 30
Study 28665989 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS + exercise (ST+EX)
Number of subjects: 30
Study 25106547 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyme honey nasal spray
Number of subjects: 64
Study 25106547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 23246640 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (400-4800 IU/d)
Number of subjects: 0
Study 23246640 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0
Study 21291438 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check‐Up (FCU) intervention
Number of subjects: 593
Study 21291438 — intervention group
Group type: COMPARATOR
Intervention: Control group (middle school services as usual)
Number of subjects: 593
Study 19473635 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral falecalcitriol
Number of subjects: 21
Study 19473635 — intervention group
Group type: COMPARATOR
Intervention: Intravenous calcitriol
Number of subjects: 21
Study 19088604 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation education sessions using a manikin with low-fidelity capabilities
Number of subjects: 74
Study 19088604 — intervention group
Group type: COMPARATOR
Intervention: Self-directed learning package (SDLP) only
Number of subjects: 74
Study 19088604 — intervention group
Group type: COMPARATOR
Intervention: SDLP plus two scenario-based PowerPoint workshops
Number of subjects: 74
Study 15209198 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline flush during vasectomy (10 mL normal saline)
Number of subjects: 106
Study 15209198 — intervention group
Group type: COMPARATOR
Intervention: Control group (no saline flush)
Number of subjects: 106
Study 12452382 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal distension inducing an urgency for defecation (average volume of air: 72.5 ml)
Number of subjects: 14
Study 12452382 — intervention group
Group type: COMPARATOR
Intervention: Control session (20 ml of air in rectal balloon)
Number of subjects: 14
Study 12452382 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal distension inducing an urgency for defecation
Number of subjects: 14
Study 12452382 — intervention group
Group type: COMPARATOR
Intervention: Both sessions (rectal distension and control)
Number of subjects: 14
Study 9690724 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (5-day administration)
Number of subjects: 14
Study 9690724 — intervention group
Group type: COMPARATOR
Intervention: Control (no omeprazole)
Number of subjects: 14
Study 8015747 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin and mineral supplementation (beta-carotene, vitamin E, selenium)
Number of subjects: 0
Study 2732142 — intervention group
Group type: EXPERIMENTAL
Intervention: FCE 22101 (1 g dose, intravenous bolus) after 750 ml water (treatment A)
Number of subjects: 60
Study 2732142 — intervention group
Group type: EXPERIMENTAL
Intervention: FCE 22101 (1 g dose, intravenous bolus) after 8 h of water restriction (treatment B)
Number of subjects: 60
Study 2732142 — intervention group
Group type: COMPARATOR
Intervention: Placebo under water restriction (treatment C)
Number of subjects: 60
Study 4606370 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 0
Study 4606370 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 0
Study 4606370 — intervention group
Group type: COMPARATOR
Intervention: Gold
Number of subjects: 0
Study 31600590 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal depression
Number of subjects: 206
Study 31600590 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal baseline depression
Number of subjects: 206
Study 31600590 — intervention group
Group type: COMPARATOR
Intervention: Non-depressed comparison mothers
Number of subjects: 206
Study 31733755 — intervention group
Group type: EXPERIMENTAL
Intervention: Comedy video (mirthful laughter)
Number of subjects: 40
Study 31733755 — intervention group
Group type: COMPARATOR
Intervention: Documentary video (control)
Number of subjects: 40